Levosalbutamol + Ambroxol + Guaifenesin Syrup Franchise in Ahmedabad

Pediatric Respiratory Syrup Supplier in Mumbai

Cough & Bronchial Therapy Syrup Distributor in Delhi

Pediatric Pulmonary Care PCD Pharma Franchise in Bangalore

Levosalbutamol Ambroxol Guaifenesin Syrup Stockist in Hyderabad
Pediatric Respiratory Syrup Manufacturer & Exporter in Chandigarh

Home/Products /levosalbutamol-0-5mg-5ml-ambroxol-15mg-5ml-guaifenesin-50mg-5ml-syrup

Cufstik LS Junior Syrup

Composition : Levosalbutamol (0.5mg/5ml) + Ambroxol (15mg/5ml) + Guaifenesin (50mg/5ml) Syrup

Dosage Form : Syrup

Packaging Type : Bottle

Packaging : 60ml

Price : ₹105/-

Cufstik LS Junior Syrup contains Levosalbutamol 0.5mg/5ml + Ambroxol 15mg/5ml + Guaifenesin 50mg/5ml, a combination used for relieving cough, loosening mucus, and easing bronchial spasms in children. It helps improve breathing comfort and reduce respiratory distress.

Levosalbutamol works by relaxing bronchial smooth muscles, Ambroxol breaks down and clears mucus, and Guaifenesin thins secretions, providing a comprehensive multi-action relief for pediatric patients.

This syrup is commonly prescribed for children with asthma, bronchitis, and other respiratory conditions requiring effective mucus clearance and bronchodilation. Its palatable liquid formulation ensures accurate dosing and better compliance in young patients.

For PCD pharma franchise partners, Cufstik LS Junior Syrup is a high-demand pediatric respiratory product, available at the best price for PCD pharma franchise. Its clinical effectiveness, strong prescriber trust, and wide acceptance make it a valuable addition to any pediatric pulmonary care or cough management product portfolio.

Read More

About the Product

Cufstik LS Junior Syrup contains Levosalbutamol 0.5mg/5ml + Ambroxol 15mg/5ml + Guaifenesin 50mg/5ml, a combination used for relieving cough, loosening mucus, and easing bronchial spasms in children. It helps improve breathing comfort and reduce respiratory distress.

Levosalbutamol works by relaxing bronchial smooth muscles, Ambroxol breaks down and clears mucus, and Guaifenesin thins secretions, providing a comprehensive multi-action relief for pediatric patients.

This syrup is commonly prescribed for children with asthma, bronchitis, and other respiratory conditions requiring effective mucus clearance and bronchodilation. Its palatable liquid formulation ensures accurate dosing and better compliance in young patients.

For PCD pharma franchise partners, Cufstik LS Junior Syrup is a high-demand pediatric respiratory product, available at the best price for PCD pharma franchise. Its clinical effectiveness, strong prescriber trust, and wide acceptance make it a valuable addition to any pediatric pulmonary care or cough management product portfolio.

Common side effects may include mild nausea, headache, restlessness, tremors, or palpitations. Rare but serious side effects include severe allergic reactions, rapid heartbeat, or difficulty breathing. Immediate medical attention should be sought if serious symptoms appear.

Cufstik LS Junior Syrup is indicated for the treatment of pediatric respiratory conditions such as asthma, bronchitis, and other illnesses associated with productive cough and airway obstruction, as prescribed by a healthcare professional.

Administer Cufstik LS Junior Syrup exactly as prescribed, using the provided measuring device for accurate dosing. Caution is advised in children with heart disease, high blood pressure, diabetes, or thyroid disorders. Avoid combining with other bronchodilators unless directed by a doctor.

Store Cufstik LS Junior Syrup in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children and do not use after the expiry date indicated on the packaging.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation